A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan List, MD
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- New York Presbyterian Hospital-Weill Cornell Medical College
New York, New York, United States
- Wake Forest University School of Medicine Bowman Gray Campus, Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- the Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2007
- Primary completion
- 1 Oct 2008
- Completion
- 1 Dec 2008
- Last update posted
- 13 Dec 2019
- Registered enrollment
- 34
- Registry id
- NCT00458159
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.